phrykt

Idexx Laboratories (IDXX) cash: $180M

Idexx Laboratories held $180M in cash and cash equivalents on Dec 31, 2025, down 37.5% from $288M a year earlier.

From Idexx Laboratories's filings with the SEC · Read the filing · IDXX stock page

Idexx Laboratories cash by year

$144M2021$113M2022$454M2023$288M2024$180M2025

#1,612 of 4,171 US companies by cash · See the full ranking

Year endedCashChange
Dec 31, 2025$180M-38%
Dec 31, 2024$288M-36%
Dec 31, 2023$454M+303%
Dec 31, 2022$113M-22%
Dec 31, 2021$144M–

Cash of similar companies

Companies in the same industry as Idexx Laboratories, by SEC industry code, with the closest cash. Each name opens the same page for that company.

CompanyCash, latest yearYear ended
Lantheus Holdings$359MDec 31, 2025
Idexx Laboratories$180MDec 31, 2025
QuidelOrtho$170MDec 28, 2025
Intellia Therapeutics$155MDec 31, 2025
Neogen$145MNov 30, 2025
Celldex Therapeutics$28.9MDec 31, 2025
Achieve Life Sciences$20.9MDec 31, 2025

Questions and answers

What is Idexx Laboratories's cash?

Idexx Laboratories held $180M in cash and cash equivalents on Dec 31, 2025, down 37.5% from $288M a year earlier.

Numbers as reported in Idexx Laboratories's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology